慢性荨麻疹登记注册研究:CURE 的原理、方法与初期实施
慢性荨麻疹(CU)以反复风团和/或血管性水肿超过6周为特征,其生物学机制尚不清楚且部分患者对推荐治疗反应不足。慢性荨麻疹登记注册研究(CURE)为持续、前瞻性、国际多中心、观察性、自愿登记注册,面向所有诊治CU患者的医生开放,无有意选择或排除标准,收集人口学、病史、症状、诱因与危险因素、治疗及医疗利用等基线及随访数据。截至2020年2月26日,全球39个中心加入,35个中心录入共2946例患者基线数据。
要点
- CURE为国际多中心前瞻性观察性登记注册,无有意选择或排除标准。
- 收集CU患者人口学、病史、症状、诱因与危险因素、治疗及医疗利用数据。
- 截至2020年2月26日,39个中心加入,35个中心录入2946例基线数据。
核心结论
- CURE是国际荨麻疹医学界的标志性成果,旨在改善对CU的科学认识、临床治疗和医疗规划。
研究设计与样本
- CURE为持续、前瞻性、国际、多中心、观察性、自愿登记注册,面向所有诊治CU患者的医生开放,不论地点、医学专业或执业类型。
- CURE旨在收集所有CU患者数据,无有意选择或排除标准,收集基线及随访数据。
主要发现
- 截至2020年2月26日,全球39个中心加入登记注册,35个中心录入共2946例患者基线数据。
- 该数据相关出版物即将发布。
临床怎么用
- CURE邀请更多医生参与,并寻求全球政府、慈善和商业赞助者支持,以改善CU患者生活。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic urticaria (CU) is a common disease, characterized by the recurrent appearance of wheals, angioedema or both for more than 6 weeks. Its underlying biology is not well understood, and many patients do not obtain sufficient relief from recommended treatments. Patient registries are rapidly growing as a form of research, because they can provide powerful, data-driven insights about the epidemiology of diseases, real-world effectiveness of treatments, rare patient types, safety monitoring, healthcare costs and opportunities for quality improvement of healthcare delivery. OBJECTIVES: The Chronic Urticaria Registry (CURE) has been designed to improve the scientific understanding, clinical treatment and healthcare planning of CU patients. This report describes the rationale, methods and initial implementation of this registry. METHODS: Chronic Urticaria Registry is an ongoing, prospective, international, multicentre, observational, voluntary registry of patients with CU. Participation in CURE is open to any physician treating CU patients, regardless of location, medical specialty or type of practice setting. CURE aims to collect data on all CU patients, with no intentional selection or exclusion criteria. It collects baseline and follow-up data on the patient's demographics, history, symptoms, trigger and risk factors, therapies and healthcare utilization. RESULTS: Chronic Urticaria Registry is a landmark achievement of the global urticaria medical community. As of 26 February 2020, 39 centres around the world have joined the registry and 35 have entered baseline data on a total of 2946 patients. Publications of this data will be forthcoming soon. CONCLUSIONS: Chronic Urticaria Registry is eagerly seeking the participation of more physicians and the support of more governmental, charitable and commercial sponsors from around the world. Here, in this paper, we invite other physicians to join this unique project to improve the lives of patients with CU.
引用
- Weller K, Giménez-Arnau A, Grattan C, et al. The Chronic Urticaria Registry: rationale, methods and initial implementation. J Eur Acad Dermatol Venereol. 2020. PMID: 32946615. doi:10.1111/jdv.16947
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。